FDA approves two new Abbott over-the-counter continuous glucose monitors

Published

11 months ago

June 10, 2024

admin

Abbott Chairman of the Board and CEO Robert B. Ford delivers a keynote address at CES 2022 at The Venetian Las Vegas on January 6, 2022 in Las Vegas, Nevada.

Ethan Miller | Getty Images

Abbott Laboratories announced on Monday it received approval from the U.S. Food and Drug Administration for two new continuous glucose monitoring systems, including one for people who don’t have diabetes. Both will be available over-the-counter without a prescription.

A continuous glucose monitor, or a CGM, is a small sensor that pokes through the skin and tracks a person’s glucose levels in real time. It wirelessly transmits this data to a smartphone. CGMs are primarily used by patients with diabetes since the tech can help alert users, their families, and their doctors to emergencies.

The market opportunity could be significant for Abbott, whose existing CGMs are already used by around 6 million patients across 60 countries, Abbot said. Around 38.4 million people are living with diabetes in the U.S. alone, Abbott said, and offering a consumer-facing CGM brings the technology to an entirely new population.

One of Abbott’s new systems, Libre Rio, is for patients with Type 2 diabetes who do not take insulin. Its second system, Lingo, is for consumers trying to improve their health and wellness, according to the company.

Abbott said Lingo users will wear a biosensor on their upper arm for 14 days at a time, and they can track their glucose data within a coaching app on their phone. Participants get access to customized coaching based on their data that can help them “retrain their metabolism and improve their overall wellbeing,” the company said.

Several companies like Signos use CGMs to help people lose weight and improve their metabolic health. Oftentimes, users need a valid CGM prescription to participate in these programs, so Abbott’s new over-the-counter offering could be more accessible for some consumers.

Libre Rio is Abbott’s first over-the-counter offering for people with diabetes in the U.S., though other CGMs within its portfolio have been available without a prescription in other countries over the last decade. Libre Rio is designed for Type 2 patients who usually manage their diabetes with lifestyle modifications, the company said.

Abbott competitor Dexcom, which also sells CGM systems, received FDA approval for its first-ever over-the-counter CGM in March.

Technology

Trump aims to cut $6 billion from NASA budget, shifting $1 billion to Mars-focused missions

Published

2 days ago

May 2, 2025

admin

Trump aims to cut billion from NASA budget, shifting billion to Mars-focused missions

The Trump administration has floated a plan to trim about $6 billion from the budget of NASA, while allocating $1 billion of remaining funds to Mars-focused initiatives, aligning with an ambition long held by Elon Musk and his rocket maker SpaceX.

A copy of the discretionary budget posted to the NASA website on Friday said that the change focuses NASA’s funding on “beating China back to the Moon and on putting the first human on Mars.”

NASA also said it will need to “streamline” its workforce, information technology services, NASA Center operations, facility maintenance, and construction and environmental compliance activities, and terminate multiple “unaffordable” missions, while reducing scientific missions for the sake of “fiscal responsibility.”

Janet Petro, NASA’s acting administrator, said in an agency-wide email on Friday that the proposed lean budget, which would cut about 25% of the space agency’s funding, “reflects the administration’s support for our mission and sets the stage for our next great achievements.”

Petro urged NASA employees to “persevere, stay resilient, and lean into the discipline it takes to do things that have never been done before — especially in a constrained environment,” according to the memo, which was obtained by CNBC. She acknowledged the budget would “require tough choices,” and that some of NASA’s “activities will wind down.”

The document on NASA’s website said it’s allocating more than $7 billion for moon exploration and “introducing $1 billion in new investments for Mars-focused programs.”

SpaceX, which is already among the largest NASA and Department of Defense contractors, has long sought to launch a manned mission to Mars. The company says on its website that its massive Starship rocket is designed to “carry both crew and cargo to Earth orbit, the Moon, Mars and beyond.”

Musk, who is the founder and CEO of SpaceX, has a central role in President Donald Trump’s administration, leading an effort to slash the size, spending and capacity of the federal government, and influencing regulatory changes through the Department of Government Efficiency (DOGE).

Musk, who frequently makes aggressive and incorrect projections for his companies, said in 2020 that he was “highly confident” that SpaceX would land humans on Mars by 2026.

Petro highlighted in her memo that under the discretionary budget, NASA would retire the SLS (Space Launch System) rocket, the Orion spacecraft and Gateway programs.

It would also put an end to its green aviation spending and to its Mars Sample Return (MSR) Program, which sought to use rockets and robotic systems to “collect and send samples of Martian rocks, soils and atmosphere back to Earth for detailed chemical and physical analysis,” according to a website for NASA’s Jet Propulsion Laboratory.

Some of the biggest reductions at NASA, should the budget get approved, would hit the space agency’s space science, Earth science and mission support divisions.

Petro didn’t name any specific aerospace and defense contractors in her agency-wide email. However SpaceX, ULA and Jeff Bezos’ Blue Origin are positioned to continue to conduct launches in the absence of the SLS. Boeing is currently the prime contractor leading the SLS program.

“This is far from the first time NASA has been asked to adapt, and your ability to deliver, even under pressure, is what sets NASA apart,” she wrote.

President Trump’s nominee to lead NASA, tech entrepreneur Jared Isaacman, still has to be approved by the U.S. Senate. His nomination was advanced out of the Senate Commerce Committee on Wednesday.

WATCH: CNBC’s interview with NASA’s astronauts on their nine months in space

Technology

Temu halts shipping direct from China as de minimis tariff loophole is cut off

Published

2 days ago

May 2, 2025

admin

Temu halts shipping direct from China as de minimis tariff loophole is cut off

Nurphoto | Nurphoto | Getty Images

Chinese bargain retailer Temu changed its business model in the U.S. as the Trump administration’s new rules on low-value shipments took effect Friday.

In recent days, Temu has abruptly shifted its website and app to only display listings for products shipped from U.S.-based warehouses. Items shipped directly from China, which previously blanketed the site, are now labeled as out of stock.

Temu made a name for itself in the U.S. as a destination for ultra-discounted items shipped direct from China, such as $5 sneakers and $1.50 garlic presses. It’s been able to keep prices low because of the so-called de minimis rule, which has allowed items worth $800 or less to enter the country duty-free since 2016.

The loophole expired Friday at 12:01 a.m. EDT as a result of an executive order signed by President Donald Trump in April. Trump briefly suspended the de minimis rule in February before reinstating the provision days later as customs officials struggled to process and collect tariffs on a mountain of low-value packages.

Jeff Bezos discloses plan to sell up to $4.8 billion in Amazon stock

Published

3 days ago

May 2, 2025

admin

Jeff Bezos discloses plan to sell up to .8 billion in Amazon stock

Jeff Bezos, founder and executive chairman of Amazon and owner of The Washington Post, takes the stage during The New York Times’ annual DealBook Summit, at Jazz at Lincoln Center in New York City, Dec. 4, 2024.

Michael M. Santiago | Getty Images

Amazon founder Jeff Bezos plans to sell up to 25 million shares in the company over the next year, according to a financial filing on Friday.

Bezos, who stepped down as CEO in 2021 but remains Amazon’s top shareholder, is selling the shares as part of a trading plan adopted on March 4, the filing states. The stake would be worth about $4.8 billion at the current price.

The disclosure follows Amazon’s first-quarter earnings report late Thursday. While profit and revenue topped estimates, the company’s forecast for operating income in the current quarter came in below Wall Street’s expectations.

The results show that Amazon is bracing for uncertainty related to President Donald Trump’s sweeping new tariffs. The company landed in the crosshairs of the White House this week over a report that Amazon planned to show shoppers the cost of the tariffs. Trump personally called Bezos to complain, and Amazon clarified that no such change was coming.

Bezos previously offloaded about $13.5 billion worth of Amazon shares last year, marking his first sale of company stock since 2021.

Since handing over the Amazon CEO role to Andy Jassy, Bezos has spent more of his time on his space exploration company, Blue Origin, and his $10 billion climate and biodiversity fund. He’s used Amazon share sales to help fund Blue Origin, as well as the Day One Fund, which he launched in September 2018 to provide education in low-income communities and combat homelessness.

WATCH: Amazon has levers to pull with tariffs